Skip to main content
. 2018 Sep 6;8:13379. doi: 10.1038/s41598-018-30780-4

Table 2.

Meta-Analysis Results.

Sensitivity (95% CI) Specificity (95% CI) PLR (95% CI) NLR (95% CI) DOR (95% CI) AUC (95% CI)
All Studies 0.67 (0.64–0.70) 0.80 (0.77–0.83) 2.67 (1.86–3.82) 0.46 (0.38–0.54) 7.27 (4.39–12.05) 0.78
Sample size Large Studies (>60 patients) 0.67 (0.64–0.71) 0.80 (0.75–0.84) 3.01 (1.86–4.89) 0.39 (0.30–0.52) 9.69 (4.36–21.55) 0.82
Sample size Small Studies (<60 patients) 0.67 (0.61–0.74) 0.81 (0.75–0.85) 2.48 (1.46–4.22) 0.53 (0.44–0.65) 5.66 (2.91–10.99) 0.74
Detection Method (RT-PCR) 0.61 (0.57–0.65) 0.82 (0.77–0.87) 2.71 (1.51–4.87) 0.50 (0.42–0.61) 6.28 (2.15–14.58) 0.70
Detection Method (dPCR) 0.72 (0.68–0.76) 0.73 (0.67–0.79) 2.16 (1.42–3.27) 0.45 (0.38–0.54) 5.67 (3.22–9.98) 0.77
Detection Method (NGS) 0.87 (0.76–0.95) 0.89 (0.82–0.94) 4.55 (1.00–20.83) 0.26 (0.06–1.20) 19.53 (1.44–264.76) 0.88

CI: confidence intervals; RT-PCR: real-time PCR; dPCR: digital-PCR; NGS: next generation sequencing; PLR: positive likelihood ratio; NLR: negative likelihood ratio; DOR: diagnostic odds ratio; AUC: area under curve.